Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Arena Sales - Pacing Along Modestly
Seeking Alpha
Friday, September 27, 2013 - 11:39am
tags:
Arena Pharmaceuticals, Eisai, Belviq
NeoStem Unfazed By Hiccup Over Its AMR-001 Cardiovascular Stem Cell Treatment
Forbes
Friday, September 27, 2013 - 11:38am
tags:
AMR-001, NeoStem
US approves Mylan's purchase of Strides unit, with conditions
Reuters
Friday, September 27, 2013 - 9:21am
tags:
Mylan, M&A, Strides Arcolab
Endocyte says Doxil supply interruption will not affect PROCEED trial
The Fly on the Wall
Friday, September 27, 2013 - 9:11am
tags:
Endocyte, Doxil, JNJ, drug shortages, vintafolide, clinical trials, etarfolatide, ovarian cancer
Will Teva Recover From Its Downfall?
Motley Fool
Friday, September 27, 2013 - 9:00am
tags:
Teva, earnings
Novartis reports new data for Lucentis backs transformational efficacy
The Fly on the Wall
Friday, September 27, 2013 - 8:59am
tags:
Novartis, Lucentis
Rough market day for Nektar, while Pharmacyclics and Regeneron soar
Marketwatch
Friday, September 27, 2013 - 8:37am
tags:
Nektar, Pharmacyclics, Regeneron, osteoarthritis, NKTR-181, ibrutinib
Amgen Plans R&D Center in China
GenEngNews
Friday, September 27, 2013 - 8:32am
tags:
Amgen, R&D, China
FDA grants two orphan drug designations for Bayer's Riociguat
Pharmaceutical Business Review
Friday, September 27, 2013 - 8:30am
tags:
FDA, orphan drugs, Bayer, Riociguat
Allergan to Pay Medytox for Neurotoxin Licensing
Motley Fool
Friday, September 27, 2013 - 8:25am
tags:
Allergan, Medytox, neurotoxins
The Billion Dollar Molecule
Seeking Alpha
Friday, September 27, 2013 - 8:24am
tags:
GSK, Pfizer, Roche, Puma Biotechnology, neratinib, breast cancer
How AbbVie Plans to Survive After Humira
Motley Fool
Friday, September 27, 2013 - 8:20am
tags:
AbbVie, Humira, Ablynx, ALX-0061
3 Companies at the Cutting Edge of Diabetes Research
Motley Fool
Friday, September 27, 2013 - 8:18am
tags:
diabetes, Eli Lilly, Merck, MannKind
J&J warns doctors Doxil shortage will hit next month
Fierce Pharma
Thursday, September 26, 2013 - 2:53pm
tags:
Doxil, ovarian cancer, JNJ, drug shortages, Sun Pharma
How Well Does Pharma Disclose Political Spending?
Pharmalot
Thursday, September 26, 2013 - 2:52pm
tags:
political spending
Could This Popular Diabetes Treatment Also Treat Alzheimer's Disease?
Motley Fool
Thursday, September 26, 2013 - 2:50pm
tags:
Alzheimer's disease, diabetes, Novo Nordisk, Victoza
3 Key Points From Sarepta's Eteplirsen Study Update (And They're Positive)
TheStreet.com
Thursday, September 26, 2013 - 10:35am
tags:
Sarepta, eteplirsen, Genentech, GSK, Duchenne Muscular Dystrophy
Boxed Warning of HBV Risk Added to Rituxan, Arezerra
Med Page Today
Thursday, September 26, 2013 - 10:28am
tags:
warnings, Rituxan, hepatitis B, Arezerra, ofatamumab, rituximab
Sanofi cholesterol drug touted as potential $3 billion blockbuster
Reuters
Thursday, September 26, 2013 - 10:25am
tags:
Sanofi, Regeneron, alirocumab, PCSK9 inhibitors
FDA distributes $3.5M to spark pediatric device development
Fierce Medical Devices
Thursday, September 26, 2013 - 10:22am
tags:
FDA, pediatrics, devices

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.